NM_000057.4:c.1934A>G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000057.4(BLM):c.1934A>G(p.Gln645Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000291 in 1,613,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000057.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250372Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135324
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461270Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 726882
GnomAD4 genome AF: 0.000158 AC: 24AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74376
ClinVar
Submissions by phenotype
Bloom syndrome Uncertain:2
- -
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 645 of the BLM protein (p.Gln645Arg). This variant is present in population databases (rs377563699, gnomAD 0.04%). This missense change has been observed in individual(s) with hematological malignancy (PMID: 33850299). ClinVar contains an entry for this variant (Variation ID: 405318). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt BLM protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
The BLM c.1934A>G (p.Gln645Arg) variant has been reported in the published literature in an individual with colorectal cancer (PMID: 28944238 (2017)) and in a cohort of individuals with multiple cancers who also had hematological disorders (PMID: 33850299 (2021)). The frequency of this variant in the general population, 0.00036 (9/24868 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33850299, 28944238) -
not specified Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Q645R variant (also known as c.1934A>G), located in coding exon 7 of the BLM gene, results from an A to G substitution at nucleotide position 1934. The glutamine at codon 645 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at